SMAD2 and Hepatic fibrosis: MSC transplantation could alleviate liver fibrosis and reduce the expression of transforming growth factor-β1 (TGF-β1), Smad2, collagen type I, and α-SMA, and pathological examination showed reduced liver fibrosis areas (72).